Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Analysis 2012-2017 and Forecast 2018-2023
ReportPage
Report ID
26100
Published Date
12-Mar
No of Report Page
112
Report Category
Editor's Rating
US $6,600.00
US $6,600.00
US $3,300.00

  • Report Details 
    Snapshot
    
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
    
The Asia-Pacific Glucagon Like Peptide-1 (GLP-1) Agonists market will reach xxx Million USD i
    More...
  • Table Of Content 
    Table of Content
    
1 Industry Overview
    
    1.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry
    
        1.1.1 Overview
    
        1.1.2 Development of Glucagon Like Peptide-1 (GLP-1) Agonists
    
    1.2 Market Segment
    
        1.2.1 By Product Type
    
        1.2.2 By Application
    
    1.3 Asia-Pacific Overview
    
2 Major Companies List
    
    2.1 Novo Nordisk (Company Profile, Products & Services, Sales Data etc.)
    More...
  • Inquiry Before Buying
    Inquiry Before Buying -
  • Request Sample
    Request For Sample
portalmarketdeskus
 
Office No 8, 3rd Floor, Aston Plaza, Katraj - Ambegaon Road, Ambegaon BK, Pune, Maharashtra, India. Pin- 411046
Navigation : -
Connect with Us : -
Secured Payment Options : -